BIOCentre – Incubation centre for biosciences’ Post

Last week, leaders from across Australia’s #lifesciences ecosystem gathered in Canberra for the first-ever National Biotech and Medtech Development and Commercialisation Summit, hosted by #AusBiotech and MTPConnect. The discussions were rich and future-focused, tackling four critical areas: health protection, commercialisation challenges, capital growth, and workforce development. From these conversations, three themes emerged, including the need for: 1️⃣ A national strategy for the life sciences sector 2️⃣ Industry to be a unified, strategic and sophisticated partner 3️⃣ Greater leverage of the industry’s expertise and knowledge Today, #AusBiotech and MTPConnect are releasing a short joint Communique that seeks to capture the major themes from the Summit, however, there is more work to do. The insights and ideas generated at the Summit and the responses to the Discussion Paper are now being fully collated, distilled and prioritised to generate actionable, forward-looking recommendations. These will inform a joint pre-budget submission for the 2024/25 Federal Budget and an upcoming White Paper, outlining a roadmap for advancing Australia’s life sciences industry. Together, we’re building a stronger future for Australia’s life sciences industry. Read the full Communique below and follow AusBiotech and MTPConnect to stay up to date with our work.  https://lnkd.in/gr8m-aEM Rebekah Cassidy, James Campbell, Karyn McIntosh, Stuart Dignam, Hon. Jaala Pulford, Caroline Duell

The latest BHI Weekly E-Newsletter is live! 🔬 ARPA-H Takes on Rare Diseases: ARPA-H’s latest project aims to deliver hope and improved outcomes to millions of Americans with rare diseases. 💡 TEDCO Invests in Sonogen Medical Inc.: TEDCO announced a $200,000 investment in Sonogen Medical, a company developing ultrasonic bone fracture healing technology. This investment will propel their research towards an efficient, cost-effective solution. 👩⚕️ Women's Health Innovation Summit USA: Join ARPA-H Director Renee Wegrzyn, PhD, and other leaders to learn about the new $100M ARPA-H Sprint for Women’s Health Program and the White House Initiative on Women’s Health Research plans. 💰 BiomX Inc Announces Merger Agreement with Adaptive Phage Therapeutics: BiomX's merger with Adaptive Phage Therapeutics will create a phage therapy company with an advanced pipeline, backed by a $50 million financing. 🚀 Virginia Commonwealth University’s Startup Accelerator to Propel University Research: Virginia Commonwealth University launched its first formal Startup Accelerator program to fast-track emerging companies based on university research with market potential. 🌐 Council on Strategic Risks: National Security and Pharmaceutical Ingredients: The COVID-19 pandemic has highlighted the need for secure pharmaceutical supply chains. The Council on Strategic Risks explores the national security imperative to address overreliance on imports for active pharmaceutical ingredients. Visit https://lnkd.in/e3K8pRi8 to read more.

The latest BHI E-Newsletter is live with stories including: 🏭 MilliporeSigma Opens €290 Million Biosafety Testing Facility: A new facility in Rockville will enhance biosafety testing services amid growing global demand. 💰 SK bioscience Acquires Stake in Fina BioSolutions LLC: A $3 million investment makes SK bioscience the first strategic investor in the Rockville-based biotech firm. 🩸 AMPEL BioSolutions Launches Heart Disease Predictive Test: A new blood test aims to predict heart disease and support therapeutic interventions. 🏥 Children's National Hospital Ranks Among Best: The facility has earned a spot on the U.S. News & World Report Honor Roll for the eighth consecutive year. 💵 TEDCO Invests $100K in Mental Health Solutions Company: A recent investment in Person Care supports digital health initiatives for complex mental health conditions. 🌍 PQE Group Recognized for Business Excellence: The company has won the Best Managed Companies Award for the fourth consecutive year in Italy. 🤝 Children’s National-led Consortium Collaborates with European Partners: A new partnership aims to accelerate pediatric medical device innovation addressing rare diseases. 📈 J.P. Morgan's Q3 2024 Life Sciences VC Update: The report highlights strong healthcare investments, rising deal activity, and a revival in the exit market for VC-backed companies. https://lnkd.in/e88jD_Yn

📣 The 2030 Vision: The Economic Potential and Future of Nordic Healthcare Join our panel of Life Science Leaders as they discuss: · How exactly can health data be leveraged to make the Nordic vision a reality? · Key challenges and opportunities of making real a new integrated and sustainable healthcare system · Potential economic effects on the Nordic region 🎙 Hear from: · Troels Bierman Mortensen, CEO, DataFair. · Frederik Knud Nielsen, Healthcare Partnerships Director, Novartis Denmark · Kenneth Forsstrøm Jensen, Health Data Lead, Roche Find out more: https://lnkd.in/e73A7vdR #LSXNordic #Biotech #Medtech #Healthtech

The latest BHI E-Newsletter is live with stories including: 🌐 Global Leadership in Clinical Research: Peter Ronco of Emmes discusses the role of AI and recent global acquisitions in the clinical research field on the BioTalk Podcast. 🗓️ BioHealth Capital Region Week Countdown: Only two weeks left to register for the BioHealth Capital Region Forum and Investment Conference. 🏢 Bisnow International Life Sciences Real Estate Conference: A two-day event exploring biotech and real estate innovations, featuring Joel Marcus and Maryland Governor Wes Moore. 🎉 Johns Hopkins Technology Ventures (JHTV) Milestone: Celebrating ten years of growth with a focus on increasing venture investments and licensing revenue. 🧬 Cartesian Therapeutics Starts Phase 1 Trial: Descartes-15, a next-gen mRNA CAR-T therapy, begins its first-in-human trial. 💉 FDA Approves Novavax COVID-19 Vaccine: Novavax's updated vaccine receives Emergency Use Authorization for individuals 12 and older. 🚀 Activation Capital’s Frontier BioHealth Program: 10 startups selected for specialized training and mentorship in the life sciences sector. 📈 OxiWear Receives FDA Clearance: OxiWear’s oxygen monitoring device gains FDA approval, advancing wearable health technology. 💰 TEDCO Invests in NEOPATHOLOGY CORP.: A $25,000 investment in rural Maryland biotech for innovative image-based diagnostics. Visit https://lnkd.in/gNYVa35M for these stories and more!

🌟 **Day 1 for Innova Solutions at the DIA Global Annual Event in San Diego!** 🌟 What an incredible start to the DIA Global Annual Event here in sunny San Diego! The energy and enthusiasm were palpable as we kicked off with insightful keynotes, engaging panel discussions, and dynamic networking opportunities. **Highlights from Day 1:** 🔹 **Opening Keynote:** Visionary insights on the future of healthcare and innovation. A powerful message about the importance of collaboration in driving progress. 🔹 **Panel Discussions:** Thought-provoking sessions on topics such as digital transformation in clinical trials, regulatory challenges, and patient-centric drug development. The experts brought diverse perspectives that sparked meaningful conversations. 🔹 **Innovation Hub:** The exhibit hall was buzzing with cutting-edge solutions and technologies. It was great to see the latest advancements in pharma and biotech up close and personal. Gen AI/ML has been the key topics in the technology space of participating organizations. 🔹 **Networking:** Connecting with industry leaders, peers, and new contacts was a highlight. The networking opportunities have been invaluable for exchanging ideas and forging new partnerships. Looking forward to the next few days of learning, sharing, and growing together. Stay tuned for more updates! DIA #DIA2024 #HealthcareInnovation #Pharma #Biotech #SanDiego #InnovaSolutions #LifeScineces

🗯️ We invite all companies interested in joining a pivotal webinar marking the launch of COBIOE (Connecting Biomanufacturing Innovation Ecosystems in Europe) working groups. COBIOE aims to interconnect innovation ecosystems across Europe to address critical challenges in the healthcare biomanufacturing sector. 🧪 This event will bring together industry leaders, researchers, and stakeholders from across the region to collaborate on strategies to enhance European competitiveness, foster regional partnerships, and pave the way for innovation and growth. Key topics: ▪️The European Commission's strategic priorities in healthcare biomanufacturing ▪️Insights and trends from industry experts ▪️Introduction to the working groups: discover our collaborative approach to tackling challenges such as scaling production, navigating regulatory landscapes, and driving innovation across the sector ➡️ Join the webinar on November 12th! Registration 👉 https://lnkd.in/dryaCkny

Keynote at Swiss Nordic Bio: Exploring the Future of Healthcare - can we square a circle?   Last Thursday, I had the privilege to give a keynote speech at the Swiss Nordic Bio conference. Did you know that the Nordic countries and Switzerland rank among the world's happiest nations? The individual freedom we have and the ability to participate in the public debate and shape our societies are critical factors driving this happiness. As such the participants broadly agreed that we need to play an active role in ensuring innovation and high quality, accessible healthcare remains a top priority for our governments and societies, particularly in this pivotal year where EU Parliament but also many local governments are being elected.   We discussed what would be needed to "square the circle" in healthcare, i.e. solve the seemingly unsolvable problem of providing broader access and better quality care to a growing and aging population in light of scarce resources. We explore the role that data and technologies can play in supporting a seamless and highly effective care journey, from prevention, to diagnosis and treatment. And we acknowledged that, while required technologies are at our fingertips, the reality in clinical practice still looks very different.   To achieve the vision of data and technology enabled, more personalized care, we must cultivate the right people, forge meaningful partnerships, and enact progressive policies.  The journey ahead may seem daunting, but with determination and collaboration, we could square the circle in healthcare.   Thank you to the event main sponsors Nasdaq and Eversheds Sutherland and partners Innovation Norway, Vontobel, Embassy of Sweden, and Innosuisse Swiss Innovation Agency.   #PersonalizedHealthcare #swissnordicbio #investors #lifescience #innovation #biotech #medtech #Nordics #Switzerland #conference #healthcare

AusBiotech 2024 promotes innovation, collaboration, commercialisation and equalisation.    Reflecting on the themes of last week's events in Melbourne, we were inspired by the economic and social impact Australia's life sciences sector is having, and by the increasing role of new technologies in addressing healthcare inequities.    We valued the opportunity to network with industry peers, explore new projects, and strengthen existing ones, setting the stage for an exciting 2025.    Throughout the week we attended and sponsored several engaging events. We thank:    • Invest Victoria and Global Victoria for their networking luncheon to welcome AmCham Australia, and their Victorian Networking Reception for health, biotech and life sciences professionals, at which welcome addresses were delivered by The Hon. Tim Pallas and Dr Amanda Caples.    • MTPConnect, Nucleus Network and Global R&D Pty Ltd for partnering with us to present ‘The Australian Advantage’ to the visiting delegation from Korea, Japan and Taiwan.    • AusBiotech CEO, Rebekah Cassidy, and Federal Minister for Health and Aged Care, The Hon. Mark Butler MP, for their keynote addresses on the opening day of the conference.     • AusBiotech and BioMelbourne Network for both their networking event and the establishment of their new MOU which will strengthen collaboration between the two organisations and benefit our industry.    • AusBiotech for recognising the life and achievements of Dr Iris Depaz from Sanofi, both through The Depaz Oration and the establishment of the Iris Depaz Award, following her sad passing.    • Life Sciences Queensland Ltd (LSQ), in particular Natalie Davis and Sally Dillon, for their networking evening. It is always great to connect with Queensland industry colleagues and partners.   We are already looking forward to next year’s meeting and the incredible progress we will have made as an industry by this time. #AusBiotech2024 #lifesciences #biotechnology #innovation #collaboration #commercialisation #equalisation #clinicaltrials #TheAustralianAdvantage